Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) Stock
Stocks
RMDA
EGS381B1C015
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.310 EGP | +9.36% |
|
+20.88% | +89.49% |
| 05-19 | Egypt's Rameda Q1 standalone profit EGP 105.2 million | RE |
| 05-19 | Rameda FY dividend/share EGP 0.03 | RE |
| Market Cap | 12.62B 254M 220M 206M 189M 356M 24.19B 361M 2.41B 947M 12.09B 954M 933M 40.23B | P/E 2026 * |
22.9x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 14.63B 294M 256M 239M 219M 413M 28.05B 419M 2.8B 1.1B 14.01B 1.11B 1.08B 46.64B | EV / Sales 2026 * |
3.06x | EV / Sales 2027 * | 2.55x |
| Free-Float |
41.49% | Yield 2026 * |
1.01% | Yield 2027 * | 2.45% |
| 1 day | +9.36% | ||
| 1 week | +20.88% | ||
| Current month | +19.51% | ||
| 1 month | +25.95% | ||
| 3 months | +39.60% | ||
| 6 months | +81.32% | ||
| Current year | +89.49% |
| 1 week | 5.28 |  | 6.6 |
| 1 month | 4.94 | | 6.6 |
| Current year | 3.06 | | 6.6 |
| 1 year | 3.02 | | 6.6 |
| 3 years | 0.99 | | 6.6 |
| 5 years | 0.8 | | 6.6 |
| 10 years | 0.8 | | 6.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 2010-12-31 |
Aboamira Mohamed
DFI | Director of Finance/CFO | - | 2014-07-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 2018-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Karim Zahran
BRD | Director/Board Member | 41 | 2017-12-31 |
Ayman Abbas
CHM | Chairman | 51 | 2010-12-31 |
Amr Morsy
BRD | Director/Board Member | - | 2010-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.36% | +20.88% | +83.56% | +494.22% | 232M | |
| +1.89% | -1.49% | +55.62% | +165.18% | 1,043B | |
| -0.24% | -3.22% | +50.51% | +52.02% | 621B | |
| -0.95% | -7.38% | +22.83% | +65.08% | 435B | |
| 0.00% | +0.83% | +42.80% | +37.60% | 361B | |
| +0.58% | -3.51% | +31.12% | +40.54% | 293B | |
| -1.55% | -9.78% | +5.61% | +8.62% | 251B | |
| -0.73% | +4.44% | +34.91% | +66.41% | 220B | |
| -0.24% | -13.15% | -4.02% | -44.69% | 201B | |
| -0.68% | -1.41% | +16.36% | +66.32% | 164B | |
| Average | +0.47% | -2.12% | +33.93% | +95.13% | 358.94B | |
| Weighted average by Cap. | -0.54% | -3.79% | +37.57% | +77.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.78B 96.19M 83.48M 78.17M 71.5M 135M 9.16B 137M 914M 359M 4.58B 361M 353M 15.24B | 5.63B 113M 98.32M 92.07M 84.22M 159M 10.79B 161M 1.08B 423M 5.39B 425M 416M 17.95B |
| Net income | 564M 11.35M 9.85M 9.23M 8.44M 15.93M 1.08B 16.14M 108M 42.36M 540M 42.63M 41.71M 1.8B | 815M 16.4M 14.24M 13.33M 12.19M 23.02M 1.56B 23.32M 156M 61.2M 781M 61.59M 60.25M 2.6B |
| Net Debt | 2.01B 40.47M 35.12M 32.88M 30.08M 56.79M 3.85B 57.53M 385M 151M 1.93B 152M 149M 6.41B | 1.72B 34.66M 30.08M 28.16M 25.76M 48.64M 3.3B 49.27M 329M 129M 1.65B 130M 127M 5.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | EGP 6.310 | +9.36% | 37,862,971 |
| 26-08-05 | EGP 5.770 | -0.52% | 18,333,608 |
| 26-08-04 | EGP 5.800 | -7.79% | 54,493,465 |
| 26-08-03 | EGP 6.290 | +12.72% | 87,656,166 |
| 26-08-02 | EGP 5.580 | +5.68% | 40,168,665 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMDA Stock
Select your edition
All financial news and data tailored to specific country editions
